La maladie de Parkinson au Canada (serveur d'exploration) - Corpus (Istex)

Index « Auteurs » - entrée « Mark Guttman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mark Griffiths < Mark Guttman < Mark H. Eckman  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000466 (2003) Mark Guttman ; Pamela M. Slaughter ; Marc-Erick Theriault ; Donald P. Deboer ; C. David NaylorBurden of parkinsonism: A population‐based study
000496 (1986) Mark Guttman ; Mark Seeman ; Gavin P. Reynolds ; Peter Riederer ; Kurt Jellinger ; Wallace W. TourtellotteDopamine D2 receptor density remains constant in treated Parkinson's disease
000693 (2009) Isabelle Boileau ; Mark Guttman ; Pablo Rusjan ; John R. Adams ; Sylvain Houle ; Junchao Tong ; Oleh Hornykiewicz ; Yoshiaki Furukawa ; Alan A. Wilson ; Shitij Kapur ; Stephen J. KishDecreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease
000720 (1997) Robert A. Hauser ; Theresa A. Zesiewicz ; Stewart A. Factor ; Mark Guttman ; William J. WeinerClinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness
000787 (1987) Philip Seeman ; Mark GuttmanDopamine receptor elevation in denervated tissues
000828 (2010) Junchao Tong ; Henry Wong ; Mark Guttman ; Lee C. Ang ; Lysia S. Forno ; Mitsunobu Shimadzu ; Ali H. Rajput ; Manfred D. Muenter ; Stephen J. Kish ; Oleh Hornykiewicz ; Yoshiaki FurukawaBrain -synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation
000856 (1992) Mark Guttman ; Gabriel Léger ; Jesse M. Cedarbaum ; Avinoam Reches ; William Woodward ; Alan Evans ; Mirko Diksic ; Mirko Gjedde3‐O‐methyldopa administration does not alter fluorodopa transport into the brain
000E42 (2003) Raúl De La Fuente-Fernández ; Sarah Furtado ; Mark Guttman ; Yoshiaki Furukawa ; Chong S. Lee ; Donald B. Calne ; Thomas J. Ruth ; A. Jon StoesslVMAT2 binding is elevated in dopa‐responsive dystonia: Visualizing empty vesicles by PET
000F11 (2005) Mark Stacy ; Annette Bowron ; Mark Guttman ; Robert Hauser ; Kim Hughes ; Jan Petter Larsen ; Peter Lewitt ; Wolfgang Oertel ; Niall Quinn ; Kapil Sethi ; Fabrizio StocchiIdentification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment
001038 (2013) Marjolein A. Van Der Marck ; Bastiaan R. Bloem ; George F. Borm ; Sebastiaan Overeem ; Marten Munneke ; Mark GuttmanEffectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial
001111 (2004) Mark Guttman ; Pamela M. Slaughter ; Marc-Erick Theriault ; Donald P. Deboer ; C. David NaylorParkinsonism in Ontario: Comorbidity associated with hospitalization in a large cohort
001136 (2005) Samer Karamohamed ; L. I. Golbe ; M. H. Mark ; A. M. Lazzarini ; O. Suchowersky ; N. Labelle ; Mark Guttman ; L. J. Currie ; G. F. Wooten ; M. Stacy ; M. Saint-Hilaire ; R. G. Feldman ; J. Liu ; C. M. Shoemaker ; J. B. Wilk ; A. L. Destefano ; J. C. Latourelle ; G. Xu ; R. Watts ; J. Growdon ; M. Lew ; C. Waters ; P. Vieregge ; P. P. Pramstaller ; C. Klein ; B. A. Racette ; J. S. Perlmutter ; A. Parsian ; Carlos Singer ; E. Montgomery ; K. Baker ; J. F. Gusella ; A. Herbert ; R. H. MyersAbsence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ‐1 (T497C) genes in familial Parkinson's disease from the GenePD study
001158 (2008) Isabelle Boileau ; Jerry J. Warsh ; Mark Guttman ; Jean A. Saint-Cyr ; Tina Mccluskey ; Pablo Rusjan ; Sylvain Houle ; Alan A. Wilson ; Jeffrey H. Meyer ; Stephen J. KishElevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB
001169 (2008) Christopher F. Mcnicoll ; Jeanne C. Latourelle ; Marcy E. Macdonald ; Mark F. Lew ; Oksana Suchowersky ; Christine Klein ; Lawrence I. Golbe ; Margery H. Mark ; John H. Growdon ; G. Frederick Wooten ; Ray L. Watts ; Mark Guttman ; Brad A. Racette ; Joel S. Perlmutter ; Anwar Ahmed ; Holly A. Shill ; Carlos Singer ; Marie H. Saint-Hilaire ; Tiffany Massood ; Karen W. Huskey ; Anita L. Destefano ; Tammy Gillis ; Jayalakshmi Mysore ; Stefano Goldwurm ; Gianni Pezzoli ; Kenneth B. Baker ; Ilia Itin ; Irene Litvan ; Garth Nicholson ; Alastair Corbett ; Martha Nance ; Edward Drasby ; Stuart Isaacson ; David J. Burn ; Patrick F. Chinnery ; Peter P. Pramstaller ; Jomana Al-Hinti ; Anette T. Moller ; Karen Ostergaard ; Scott J. Sherman ; Richard Roxburgh ; Barry Snow ; John T. Slevin ; Franca Cambi ; James F. Gusella ; Richard H. MyersHuntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study
001198 (2003) Sudeep S. Gill ; Paula A. Rochon ; Mark Guttman ; Andreas LaupacisThe Value of Positron Emission Tomography in the Clinical Evaluation of Dementia
001221 (2004) Junchao Tong ; Paul S. Fitzmaurice ; Lee Cyn Ang ; Yoshiaki Furukawa ; Mark Guttman ; Stephen J. KishBrain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
001322 (2008) Stephen J. Kish ; Junchao Tong ; Oleh Hornykiewicz ; Ali Rajput ; Li-Jan Chang ; Mark Guttman ; Yoshiaki FurukawaPreferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
001967 (2004) C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio StocchiLevodopa in the treatment of Parkinson's disease: Current controversies
001F64 (2003) Paul S. Fitzmaurice ; Lee Ang ; Mark Guttman ; Ali H. Rajput ; Yoshiaki Furukawa ; Stephen J. KishNigral glutathione deficiency is not specific for idiopathic Parkinson's disease
002215 (1989) Voon Wee Yong ; Mark Guttman ; Seung U. Kim ; Donald B. Calne ; Ian Turnbull ; Kazuhiko Watabe ; R. Ward W. TomlinsonTransplantation of human sympathetic neurons and adrenal chromaffin cells into parkinsonian monkeys: no reversal of clinical symptoms
002458 (2000) Yoshiaki Furukawa ; Mark Guttman ; Steven P. Sparagana ; Joel M. Trugman ; Keith Hyland ; Philip Wyatt ; Anthony E. Lang ; Guy A. Rouleau ; Mitsunobu Shimadzu ; Stephen J. KishDopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i -k "Mark Guttman" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Corpus/Author.i  \
                -Sk "Mark Guttman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Istex
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    Mark Guttman
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022